These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2352480)

  • 1. Nerve conduction velocity in dogs is reduced by diabetes and not by galactosemia.
    Engerman RL; Kern TS; Larson ME
    Metabolism; 1990 Jun; 39(6):638-40. PubMed ID: 2352480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs.
    Engerman RL; Kern TS; Larson ME
    Diabetologia; 1994 Feb; 37(2):141-4. PubMed ID: 8163047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal hemodynamics in experimentally galactosemic dogs and diabetic dogs.
    Kern TS; Engerman RL
    Metabolism; 1991 May; 40(5):450-4. PubMed ID: 1902544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia.
    Engerman RL; Kern TS
    Arch Ophthalmol; 1995 Mar; 113(3):355-8. PubMed ID: 7887850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does galactose feeding provide a valid model of consequences of exaggerated polyol-pathway flux in peripheral nerve in experimental diabetes?
    Willars GB; Lambourne JE; Tomlinson DR
    Diabetes; 1987 Dec; 36(12):1425-31. PubMed ID: 3678622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular filtration function in galactose-fed versus diabetic rats: the role of polyol pathway activity.
    Pugliese G; Tilton RG; Speedy A; Chang K; Province MA; Kilo C; Williamson JR
    Metabolism; 1990 Jul; 39(7):690-7. PubMed ID: 2114513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral nerve structure and function in long-term galactosemic dogs: morphometric and electron microscopic analyses.
    Sugimoto K; Kasahara T; Yonezawa H; Yagihashi S
    Acta Neuropathol; 1999 Apr; 97(4):369-76. PubMed ID: 10208276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated blood viscosity in alloxan diabetic dogs and experimentally galactosemic dogs.
    Kern TS; Engerman RL; Peterson CM
    J Diabet Complications; 1989; 3(3):158-62. PubMed ID: 2528559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
    Ng TF; Lee FK; Song ZT; Calcutt NA; Lee AY; Chung SS; Chung SK
    Diabetes; 1998 Jun; 47(6):961-6. PubMed ID: 9604875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mice overexpressing aldose reductase in Schwann cells show more severe nerve conduction velocity deficit and oxidative stress under hyperglycemic stress.
    Song Z; Fu DT; Chan YS; Leung S; Chung SS; Chung SK
    Mol Cell Neurosci; 2003 Aug; 23(4):638-47. PubMed ID: 12932443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of nerve conduction deficit with increased Na(+)-K(+)-ATPase activity in galactose-fed mice. Implications for polyol pathway and diabetic neuropathy.
    Calcutt NA; Tomlinson DR; Biswas S
    Diabetes; 1990 Jun; 39(6):663-6. PubMed ID: 2161366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney morphology in experimental hyperglycemia.
    Kern TS; Engerman RL
    Diabetes; 1987 Feb; 36(2):244-9. PubMed ID: 3803734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycemia and development of glomerular pathology: diabetes compared with galactosemia.
    Engerman RL; Kern TS
    Kidney Int; 1989 Jul; 36(1):41-5. PubMed ID: 2811056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental galactosemia produces diabetic-like retinopathy.
    Engerman RL; Kern TS
    Diabetes; 1984 Jan; 33(1):97-100. PubMed ID: 6360771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Yorek MA
    Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.
    Kowluru RA; Tang J; Kern TS
    Diabetes; 2001 Aug; 50(8):1938-42. PubMed ID: 11473058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes.
    Greene DA; De Jesus PV; Winegrad AI
    J Clin Invest; 1975 Jun; 55(6):1326-36. PubMed ID: 124320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a new aldose reductase inhibitor, 8'-chloro-2',3'-dihydrospiro [pyrrolidine-3,6'(5'H)-pyrrolo[1,2,3-de] [1,4]benzoxazine]-2,5,5'- trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats.
    Hirata Y; Fujimori S; Okada K
    Metabolism; 1988 Feb; 37(2):159-63. PubMed ID: 2828821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycemia as a cause of diabetic retinopathy.
    Engerman RL; Kern TS
    Metabolism; 1986 Apr; 35(4 Suppl 1):20-3. PubMed ID: 3083205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.